The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Tranexamic acid: a clinical review
Abstract
Blood loss and subsequent transfusions are associated with major morbidity and mortality. The use of antifibrinolytics can reduce blood loss in cardiac surgery, trauma, orthopedic surgery, liver surgery and solid organ transplantation, obstetrics and gynecology, neurosurgery and non-surgical diseases. The evidence of their efficacy has been mounting for years. Tranexamic acid (TXA), a synthetic lysine-analogue antifibrinolytic, was first patented in 1957 and its use has been increasing in contrast to aprotinin, a serine protease inhibitor antifibrinolytic. This review aims to help acute care physicians navigate through the clinical evidence available for TXA therapy, develop appropriate dose regimens whilst minimizing harm, as well as understand its broadening scope of applications. Many questions remain unanswered regarding other clinical effects of TXA such as anti-inflammatory response to cardiopulmonary bypass, the risk of thromboembolic events, adverse neurological effects such as seizures, and its morbidity and mortality, all of which necessitate further clinical trials on its usage and safety in various clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferraris, V. A., Brown, J. R., Despotis, G. J., Hammon, J. W., Reece, T. B., Saha, S. P., Song, H. K., Clough, E. R., Shore-Lesserson, L. J., Goodnough, L. T., et al. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.11.078 · Cited by 1,289
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Fergusson, D. A., Hébert, P. C., Mazer, C. D., Fremes, S., MacAdams, C., Murkin, J. M., Teoh, K., Duke, P. C., Arellano, R., Blajchman, M. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802395 · Cited by 1,152
The Risk Associated with Aprotinin in Cardiac Surgery
Mangano, D. T., Tudor, I. C., & Dietzel, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051379 · Cited by 1,099
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Henry, D. A., Carless, P. A., Moxey, A. J., O’Connell, D. L., Stokes, B., Fergusson, D. A., & Ker, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001886.pub4 · Cited by 1,065
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
Ker, K., Edwards, P., Perel, P., Shakur, H., & Roberts, I. (2012) · BMJ · doi:10.1136/bmj.e3054 · Cited by 997
The Coagulopathy of Trauma: A Review of Mechanisms
Hess, J. R., Brohi, K., Dutton, R. P., Hauser, C. J., Holcomb, J. B., Kluger, Y., Mackway-Jones, K., Parr, M. J., Rizoli, S. B., Yukioka, T., et al. (2008) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e3181877a9c · Cited by 933
Harker, L. A., Malpass, T. W., Branson, H., Hessel, E. A., & Slichter, S. J. (1980) · PubMed · doi:10.1182/blood.v56.5.824.824 · Cited by 656
Tranexamic Acid: A Review of its Use in the Treatment of Hyperfibrinolysis
McCormack, P. L. (2012) · Drugs · doi:10.2165/11209070-000000000-00000 · Cited by 640
Metadata
- Authors
- Ng, W. C. K., Jerath, A., & Wasowicz, M.
- Venue
- Anestezjologia Intensywna Terapia
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2015-09-22
- Volume
- 47
- Issue
- 4
- Pages
- 339-350
- ISSN
- 0209-1712 (ISSN-L)
- 1731-2515
- 1642-5758
- OpenAlex
- W1976511219
- Cited by
- 325
- References
- 92
- FWCI
- 8.71
- Type
- journal article
- Language
- pl
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tranexamic acid: a clinical review. https://app.cochat.ai/papers/10.5603/ait.a2015.0011
- The paper
- Ng, W. C. K., Jerath, A., & Wasowicz, M. (2015). Tranexamic acid: a clinical review. Anestezjologia Intensywna Terapia. https://doi.org/10.5603/ait.a2015.0011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.